GSK plc reported that on March 11, 2026, it purchased 513,409 shares at a price range of 2,047.00p to 2,078.00p per share as part of its ongoing buyback program, totaling 8,690,409 shares bought since February 17, 2026. This results in a treasury share proportion of 6.11% of the voting rights.